Journals / Journal of Turkish Spinal Surgery / 2020 / Cilt: 31 - Sayı: 2

RADIOFREQUENCY ABLATION PLUS VERTEBROPLASTY IN THE TREATMENT OF SYMPTOMATIC VERTEBRAL HEMANGIOMAS WITHOUT NEUROLOGICAL DEFICIT

Pages
85–87
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RF ablation plus vertebroplasty can be used separately in the treatment of symptomatic VHs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The most common benign neoplasms of the spine are vertebral hemangiomas (VH).
📊
Key Findings & Data:This study aims to demonstrate the safety of radiofrequency (RF) ablation plus vertebroplasty in the treatment of VHs.
💡
Conclusion & Impact:RF ablation plus vertebroplasty can be used separately in the treatment of symptomatic VHs.
🔬Design:Review & Systematic Survey
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: The most common benign neoplasms of the spine are vertebral hemangiomas (VH). This study aims to demonstrate the safety of radiofrequency (RF) ablation plus vertebroplasty in the treatment of VHs. Materials and Methods: The records of patients who underwent percutaneous RF ablation and vertebroplasty for the treatment of symptomatic VH between 2016 and 2018 were retrospectively reviewed and included in this study. The visual analogue scale (VAS) was used to measure the pain immediately after the procedure and in the first and sixth postoperative months. Results: The average follow-up period was 23.6 months. The average duration of the procedure was 45.7 min. VAS score with activity was 5.29±1.2 before the operation and improved to 2.14±1.3 immediately after the operative (p=0.0309). It was 0.7±0.3 in the first month and 0.3±0.2 in the sixth month postoperatively (p=0.0010). Conclusion: Although only 1% of all VHs become symptomatic, symptomatic VHs cause disability during daily life. RF ablation plus vertebroplasty can be used separately in the treatment of symptomatic VHs.

🔖

Cite This Article

ERŞEN, Ö., TÜZÜN, H. Y., KILINÇ, N. S., BİLEKLİ, A. B., EGE, T. (2020). RADIOFREQUENCY ABLATION PLUS VERTEBROPLASTY IN THE TREATMENT OF SYMPTOMATIC VERTEBRAL HEMANGIOMAS WITHOUT NEUROLOGICAL DEFICIT. Journal of Turkish Spinal Surgery, Cilt: 31 - Sayı: 2, 85–87. https://ajindex.com/articles/165267

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Koch G, Cazzato RL, Gilkison A, Caudrelier J, Garnon J, Gangi A. Percutaneous Treatments of Benign Bone Tumors. Semin Intervent Radiol. 2018;35:324-2
  2. Fox MW, Onofrio BM. The natural history and management of symptomatic and asymptomatic vertebral hemangiomas. J Neurosurg. 1993;78:36-45
  3. Liu XW, Jin P, Wang LJ, Li M, Sun G. Vertebroplasty in the treatment of symptomatic vertebral haemangiomas without neurological deficit. Eur Radiol. 2013; 23:2575-81
  4. Cloran FJ, Pukenas BA, Loevner LA, Aquino C, Schuster J, Mohan S. Aggressive spinal haemangiomas: imaging correlates to clinical presentation with analysis of treatment algorithm and clinical outcomes. Br J Radiol. 2015;88:20140771
  5. Murphey MD, Fairbairn KJ, Parman LM, Baxter KG, Parsa MB, Smith WS. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics. 1995;15:893-917
  6. Chen HI, Heuer GG, Zaghloul K, Simon SL, Weigele JB, Grady MS. Lumbar vertebral hemangioma presenting with the acute onset of neurological symptoms. Case report. J Neurosurg Spine. 2007;7:80-5
  7. Jiang L, Liu XG, Yuan HS, Yang SM, Li J, Wei F, et al. Diagnosis and treatment of vertebral hemangiomas with neurologic deficit: a report of 29 cases and literature review. Spine J. 2014;14:944-54
  8. Korkmaz MF, Saraç K, Karakaplan M, Görmeli G, Erdem MN, Selçuk EB. Evaluation of the Efficacy and Safety of Surgical Treatment of Multilevel Vertebral Hemangiomas Causing Cord Compression. J Turk Spinal Surg. 2014;25:211-8
  9. Acosta FL Jr, Sanai N, Chi JH, Dowd CF, Chin C, Tihan T, et al. Comprehensive management of symptomatic and aggressive vertebral hemangiomas. Neurosurg Clin N Am. 2008;19:17-29
  10. Kelley SP, Ashford RU, Rao AS, Dickson RA. Primary bone tumours of the spine: a 42-year survey from the Leeds Regional Bone Tumour Registry. Eur Spine J. 2007; 16:405-9
  11. Tomasian A, Wallace AN, Jennings JW. Benign Spine Lesions: Advances in Techniques for Minimally Invasive Percutaneous Treatment. AJNR Am J Neuroradiol. 2017;38:852-61
  12. Gage AA, Baust JG. Cryosurgery for tumors. J Am Coll Surg 2007; 205:342–56
  13. Rybak LD, Gangi A, Buy X, La Rocca Vieira R, Wittig J. Thermal ablation of spinal osteoid osteomas close to neural elements: technical considerations. AJR Am J Roentgenol. 2010;195:293-8
  14. Kastler A, Alnassan H, Aubry S, Alemann G, Barbe D, Aubry S, et al. Microwave thermal ablation of spinal metastatic bone tumors. J Vasc Interv Radiol. 2014;25:1470-5
  15. Gangi A, Buy X. Percutane